InvestorsHub Logo

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating
profile icon
muniros Free
12/10/10 12:07 PM
profile icon
buhg1b Free
04/29/08 11:57 AM
profile icon
buhg1b Free
04/17/08 10:17 AM
profile icon
buhg1b Free
04/01/08 11:33 AM

Beckman Coulter Incorporated (BEC) RSS Feed

Followers
0
Posters
2
Posts (Today)
0
Posts (Total)
4
Created
03/31/08
Type
Free
Moderators
Headquarters 4300 N Harbor Boulevard Fullerton, CA 92834-3100 Phone: 800-742-2345 Fax: 800-643-4366 www.beckmancoulter.com Background Beckman Coulter, Inc. provides biomedical testing instrument systems, tests, and supplies for clinical laboratories worldwide. The company offers chemistry systems, such as routine chemistry systems that use electrochemical detection, chemical reactions with patient samples, and antigen-antibody reactions to detect and quantify substances of diagnostic interest in blood, urine, and other body fluids; point of care testing products comprising rapid diagnostic test kits and hematology instruments that give physicians information to manage patient treatment; and manual and automated electrophoresis products. It also provides immunoassay systems performing tests that assess thyroid function, screen and monitor for cancer and cardiac risk, provide information in fertility and reproductive testing, and monitor factors associated with anemia, blood viruses, infectious disease, and therapeutic drugs. In addition, the company offers cellular systems for clinicians, such as hematology systems to study formed elements in blood, such as red and white blood cells and platelets; hemostasis systems offering information to diagnose bleeding and clotting disorders and to monitor anticoagulant therapy; and flow cytometry systems used in applications in basic research, clinical research, and drug discovery. Its discovery and automation products include clinical laboratory automation systems, life sciences automation products, biomarker discovery, genetic analysis systems, centrifugation, particle characterization, life sciences tools, and molecular diagnostics. The company's products are used in various applications ranging from lab solutions used for medical research, clinical research, and drug discovery to diagnostic systems in hospitals and physicians' offices to aid in patient care. The company was founded in 1934. It was formerly known as Beckman Instruments, Inc. and changed its name to Beckman Coulter, Inc. in 1998. Beckman Coulter is headquartered in Fullerton, California. Management Mr. Scott T. Garrett, 58 Chief Exec. Officer, Pres Like all successful life sciences companies, test/diagnostic giant Beckman Coulter (Fullerton, CA) is a mixture of entrepreneurial spirit and technical expertise. Chief executive officer Scott Garrett thus seems a perfect fit. The 55-year-old Garrett was named Beckman's CEO in February, three years after joining the company as president of its clinical diagnostics division. Prior to joining Beckman, Garrett had spent the past several years working for himself. He founded Garrett Capital Advisors in 1998, forming an alliance with Chicago Equity Capital. The two ventures acquired several medical device and life science companies. Garrett served on the boards of several of the companies and briefly as CEO of Kendro Laboratory Products, which recently merged with Thermo Electron Corp. (Waltham, MA). A mechanical engineer by training, Garrett began his career working in the product research and development arena with Baxter International, but eventually segued into business development and management. He headed several Baxter divisions before being named president of its global laboratory products division. A decade ago he helped spin that division off into Dade International, now Dade Behring Inc. (Deerfield, IL). Beckman Coulter, renowned over the years for introducing many diagnostic tests that are industry standards, reported 2004 sales of $2.4 billion, a 9.8% increase from 2003. About two-thirds of the company's sales are derived from after-market reagents, test kits, and consumables. Garrett predicts a similar increase in 2005 sales, led by strong growth in the company's clinical diagnostics division, particularly in the area of laboratory automation. In April, Garrett consummated his first transaction as CEO, acquiring Agencourt Bioscience Corp. (Beverly, MA) for $140 million and giving Beckman greater range in offering DNA and RNA diagnostic products. Healthcare IT For many medical technology executives, the growing emphasis on information technologies in healthcare conjures a universe that is largely unknown territory. The landscape of healthcare IT is populated by companies and associations that are outside the experience of most medtech leaders, making it difficult to find a common language for discussion. Fortunately, not everyone considers healthcare IT to be such a foreign land. Following is the profile of one executive who is well positioned to lead medical device companies into the brave new world of healthcare IT, and who has begun to make his influence felt during the past year. http://www.devicelink.com/mx/archive/05/07/medexec_x.html Mr. Charles P. Slacik CPA, 53 Chief Financial Officer and Sr. VP Mr. Robert W. Kleinert, 56 Exec. VP of Worldwide Commercial Operations Mr. Arnold A. Pinkston, 49 Sr. VP, Sec. and Gen. Counsel Mr. J. Robert Hurley, 58 Sr. VP of HR and Sr. VP of Corp. Communications Governance Beckman Coulter Inc.'s Corporate Governance Quotient (CGQ®) as of 18-Mar-08 is better than 54.7% of S&P 400 companies and 85% of Health Care Equipment & Services companies. Basics Exchange: New York Stock Exchange Index Membership: S&P 400 MidCap Sector: Technology Industry: Scientific & Technical Instruments Full Time Employees: 10,500 Fundamentals Total Cash (mrq): 83.00M Total Cash Per Share (mrq): 1.324 Total Debt (mrq): 990.80M Book Value Per Share (mrq): 22.957 Operating Cash Flow (ttm): 397.10M Levered Free Cash Flow (ttm): 24.92M Ownership Shares Outstanding: 62.70M % Held by Insiders1: 0.63% % Held by Institutions: 88.70% Major shareholders Capital Research, Earnest Partners, Barclays, Morgan Stanley, etc. http://finance.yahoo.com/q/mh?s=BEC Stock price King Capital Investment Group http://kingcapital.tripod.com
Most Liked Posts
(Last 30 Days)
Volume:
Day Range:
Last Trade Time:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
BEC Latest News
  • No Recent News Available for this company!
Most Liked Posts
(Last 30 Days)
New Post